BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7102090)

  • 1. [Effects of antiarrhythmia agents and sympathetic regulation of the heart].
    Kaverina NV; Darinskiĭ NV; Berdiaev SIu
    Vestn Akad Med Nauk SSSR; 1982; (5):23-8. PubMed ID: 7102090
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenergic innervation of the heart as a site for the genesis and control of arrhythmia.
    Roberts J; Kelliher GJ
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():357-66. PubMed ID: 4806660
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of the sympathetic nervous system in the protective effect of the selective kappa-opiate agonist dynorphin A(1-13) on frequency of cardiac arrhythmias during myocardial ischemia].
    Mikhaĭlova SD; Vasil'eva TV; Semushkina TM; Storozhakov GI
    Biull Eksp Biol Med; 2000 Jan; 129(1):34-7. PubMed ID: 10710623
    [No Abstract]   [Full Text] [Related]  

  • 4. [The sympathetic nervous system and sudden cardiac death].
    Schwartz PJ
    G Ital Cardiol; 1981; 11(9):1191-7. PubMed ID: 7035263
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
    Witkowska M
    Kardiol Pol; 1982; 25(2):147-61. PubMed ID: 6125621
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute myocardial ischaemia, neural reflexes and ventricular arrhythmias.
    Lombardi F
    Eur Heart J; 1986 May; 7 Suppl A():91-7. PubMed ID: 3720778
    [No Abstract]   [Full Text] [Related]  

  • 7. [Choice of cardiac antiarrhythmia agents].
    Kappenberger L; Biollaz J
    Ther Umsch; 1987 Aug; 44(8):591-5. PubMed ID: 3672412
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacology of antiarrhythmia agents: the new aspects].
    Kaverina NV; Chichkanov GG
    Eksp Klin Farmakol; 2003; 66(2):46-52. PubMed ID: 12962048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding and treating arrhythmias accompanying myocardial infarction.
    Biddle TL; Yu PN
    Nurs Clin North Am; 1972 Sep; 7(3):481-90. PubMed ID: 4483255
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of the novel III class anti-arrhythmia preparation (AL-275) in experimental myocardium and sympathetic stimulation].
    Kaverina NV; Lyskovtsev VV; Kishchuk EP
    Eksp Klin Farmakol; 2001; 64(1):33-7. PubMed ID: 11544801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cardiac nerve stimulation on ventricular arrhythmias after coronary occlusion.
    Sugimoto T; Sato K; Takeuchi J
    Jpn Heart J; 1971 Jul; 12(4):368-75. PubMed ID: 4104298
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrophysiologic actions of UM-272 (Pranolium) on reentrant ventricular arrhythmias in postinfarction canine myocardium.
    Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1980 Aug; 214(2):347-53. PubMed ID: 7391982
    [No Abstract]   [Full Text] [Related]  

  • 13. [Abolition by iloprost of tachycardia induced by transient myocardial ischemia in non-anesthesized dogs].
    Rimoldi O; Pierini S; Sandrone G; Songini MG; Pagani M
    Cardiologia; 1987 Jan; 32(1):77-80. PubMed ID: 2438043
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-arrhythmia and antifibrillatory effect of flecainide in programmed ventricle stimulation and in recent heart infarction].
    Thale J; Gülker H; Bender F; Heuer H
    Med Welt; 1982 Jul; 33(26):965-6. PubMed ID: 7109955
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of ouabain-induced arrhythmia and nonuniformity in the histamine-evoked discharge of cardiac sympathetic nerves.
    Lathers CM; Roberts J; Kelliher GJ
    J Pharmacol Exp Ther; 1977 Nov; 203(2):467-79. PubMed ID: 909075
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of the mechanisms of the anti-arrhythmic action of marcaine and lidocaine].
    Kaverina NV; Darinskiĭ NV; Berdiaev SIu; Dzhaparidze MM
    Farmakol Toksikol; 1984; 47(3):46-50. PubMed ID: 6734807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of the anti-arrhythmic effect of Rhodiola rosea extract].
    Maslov LN; Lishmanov IuB; Maĭmeskulova LA; Krasnov EA
    Biull Eksp Biol Med; 1998 Apr; 125(4):424-6. PubMed ID: 9631727
    [No Abstract]   [Full Text] [Related]  

  • 18. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrical stimulation studies with quinacainol, a putative 1C agent, in the anaesthetised rat.
    Howard PG; Walker MJ
    Proc West Pharmacol Soc; 1990; 33():123-7. PubMed ID: 2274522
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peptide correction of arrhythmias induced by stimulation of the vagal sympathetic trunk in cats].
    Osadchiĭ OE; Pokrovskiĭ VM
    Patol Fiziol Eksp Ter; 1997; (3):10-3. PubMed ID: 9312711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.